Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells

Authors

Daniel W. Sherbenou, University of California, San Francisco
Blake T. Aftab, University of California, San Francisco
Yang Su, University of California, San Francisco
Christopher R. Behrens, University of California, San Francisco
Arun Wiita, University of California, San Francisco
Aaron C. Logan, University of California, San Francisco
Diego Acosta-Alvear, University of California, San Francisco
Byron C. Hann, University of California, San Francisco
Peter Walter, University of California, San Francisco
Marc A. Shuman, University of California, San Francisco
Xiaobo Wu, Washington University School of Medicine in St. Louis
John P. Atkinson, Washington University School of Medicine in St. Louis
Jeffrey L. Wolf, University of California, San Francisco
Thomas G. Martin, University of California, San Francisco
Bin Liu, University of California, San Francisco

Journal

The Journal of Clinical Investigation

Publication Date

2016

Volume

126

Issue

12

Inclusive Pages

4640-4653

Document Type

Open Access Publication

DOI

10.1172/JCI85856

Rights and Permissions

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. Daniel W. Sherbenou, Blake T. Aftab, Yang Su, Christopher R. Behrens, Arun Wiita, Aaron C. Logan, Diego Acosta-Alvear, Byron C. Hann, Peter Walter, Marc A. Shuman, Xiaobo Wu, John P. Atkinson, Jeffrey L. Wolf, Thomas G. Martin, and Bin Liu. Published December 1, 2016. J Clin Invest. 2016;126(12):4640-4653. doi:10.1172/JCI85856.

Recommended Citation

Sherbenou, Daniel W.; Aftab, Blake T.; Su, Yang; Behrens, Christopher R.; Wiita, Arun; Logan, Aaron C.; Acosta-Alvear, Diego; Hann, Byron C.; Walter, Peter; Shuman, Marc A.; Wu, Xiaobo; Atkinson, John P.; Wolf, Jeffrey L.; Martin, Thomas G.; and Liu, Bin, "Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells." The Journal of Clinical Investigation. 126, 12. 4640-4653. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5475